Moderna Starts Late-Stage Trial of Bird Flu Vaccine in US, UK
April 21 (Reuters) – Moderna said on Tuesday it had started a late-stage study of its experimental bird flu vaccine in the U.S. and the UK, marking the first time a pandemic bird flu vaccine made with mRNA technology has reached late-stage trials. The U.S. drugmaker’s vaccine, known as mRNA-1018, will be tested on about …